Recurrent non-invasive breast tumours may not always be related to the primary lesion

Safety and efficacy of olaparib plus metronomic cyclophosphamide and metformin in advanced/metastatic endometrial cancer

Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid tumours

The adverse events atlas, towards a strategy to predict synergistic adverse events of combination therapies

Safety and efficacy of the oral ATR inhibitor elimusertib in advanced solid tumours with DNA damage response defects

PETRA: Next generation PARP1-selective inhibitor AZD5305 in patients with BRCA1/2, PALB2 or RAD51C/D mutations

Novel COVID-19 vaccine for B-cell deficient patients

Paediatric cancer patients in LMICS faced significantly higher mortality risk during the COVID-19 pandemic

FAP-targeted PET imaging in cancer patients

FAP-targeted molecular radiotherapy in cancer patients

Immune gene signatures for predicting response to neoadjuvant chemoimmunotherapy in NSCLC

METNET: A phase II trial of metformin in patients with well differentiated neuroendocrine tumours